These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 10049829)
21. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. Abdel-Mageed A; Agrawal KC Cancer Gene Ther; 1997; 4(3):199-207. PubMed ID: 9171939 [TBL] [Abstract][Full Text] [Related]
22. Amplification and proviral activation of several Wnt genes during progression and clonal variation of mouse mammary tumors. Roelink H; Wagenaar E; Nusse R Oncogene; 1992 Mar; 7(3):487-92. PubMed ID: 1549363 [TBL] [Abstract][Full Text] [Related]
23. Insertional mutation of int protooncogenes in the mammary tumors of a new strain of mice derived from the wild in China: normal- and tumor-tissue-specific expression of int-3 transcripts. Sarkar NH; Haga S; Lehner AF; Zhao W; Imai S; Moriwaki K Virology; 1994 Aug; 203(1):52-62. PubMed ID: 8030284 [TBL] [Abstract][Full Text] [Related]
24. Growth inhibition of human papillomavirus 16 DNA-positive mouse tumor by antisense RNA transcribed from U6 promoter. He Y; Huang L Cancer Res; 1997 Sep; 57(18):3993-9. PubMed ID: 9307284 [TBL] [Abstract][Full Text] [Related]
25. Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines. Nakamura K; Hongo A; Kodama J; Miyagi Y; Yoshinouchi M; Kudo T Cancer Res; 2000 Feb; 60(3):760-5. PubMed ID: 10676665 [TBL] [Abstract][Full Text] [Related]
26. Increased growth of NIH/3T3 cells by transfection with human p120 complementary DNA and inhibition by a p120 antisense construct. Perlaky L; Valdez BC; Busch RK; Larson RG; Jhiang SM; Zhang WW; Brattain M; Busch H Cancer Res; 1992 Jan; 52(2):428-36. PubMed ID: 1728415 [TBL] [Abstract][Full Text] [Related]
27. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment. Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884 [TBL] [Abstract][Full Text] [Related]
28. Identification of a MMTV insertion mutation within the coding region of the Fgf-3 protooncogene. Morris DW; Dutra JC Virology; 1997 Nov; 238(1):161-5. PubMed ID: 9375020 [TBL] [Abstract][Full Text] [Related]
29. MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways. Callahan R; Smith GH Oncogene; 2000 Feb; 19(8):992-1001. PubMed ID: 10713682 [TBL] [Abstract][Full Text] [Related]
30. Endogenous fibroblast growth factor-1 or fibroblast growth factor-2 modulate prostate cancer cell proliferation. Shain SA; Sarić T; Ke LD; Nannen D; Yoas S Cell Growth Differ; 1996 May; 7(5):573-86. PubMed ID: 8732667 [TBL] [Abstract][Full Text] [Related]
31. Characterization of Wnt-1 and Wnt-2 induced growth alterations and signaling pathways in NIH3T3 fibroblasts. Bafico A; Gazit A; Wu-Morgan SS; Yaniv A; Aaronson SA Oncogene; 1998 May; 16(21):2819-25. PubMed ID: 9652750 [TBL] [Abstract][Full Text] [Related]
32. Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene. Belletti B; Ferraro P; Arra C; Baldassarre G; Bruni P; Staibano S; De Rosa G; Salvatore G; Fusco A; Persico MG; Viglietto G Oncogene; 1999 Aug; 18(34):4860-9. PubMed ID: 10490819 [TBL] [Abstract][Full Text] [Related]
33. Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice. Yamazaki M; Akahane T; Buck T; Yoshiji H; Gomez DE; Schoeffner DJ; Okajima E; Harris SR; Bunce OR; Thorgeirsson SS; Thorgeirsson UP Carcinogenesis; 2004 Sep; 25(9):1735-46. PubMed ID: 15166086 [TBL] [Abstract][Full Text] [Related]
34. Control of the three-dimensional growth pattern of mammary epithelium: role of genes of the Wnt and erbB families studied using reconstituted epithelium. Edwards PA Biochem Soc Symp; 1998; 63():21-34. PubMed ID: 9513708 [TBL] [Abstract][Full Text] [Related]
35. Evidence for the transforming activity of a truncated Int6 gene, in vitro. Rasmussen SB; Kordon E; Callahan R; Smith GH Oncogene; 2001 Aug; 20(38):5291-301. PubMed ID: 11536042 [TBL] [Abstract][Full Text] [Related]
36. Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types. Cadieux C; Kedinger V; Yao L; Vadnais C; Drossos M; Paquet M; Nepveu A Cancer Res; 2009 Sep; 69(18):7188-97. PubMed ID: 19738070 [TBL] [Abstract][Full Text] [Related]
37. Creating a conditional mutation of Wnt-1 by antisense transgenesis provides evidence that Wnt-1 is not essential for spermatogenesis. Erickson RP; Lai LW; Grimes J Dev Genet; 1993; 14(4):274-81. PubMed ID: 8222343 [TBL] [Abstract][Full Text] [Related]
38. Differential gene expression in mouse mammary adenocarcinomas in the presence and absence of wild type p53. Cui XS; Donehower LA Oncogene; 2000 Dec; 19(52):5988-96. PubMed ID: 11146550 [TBL] [Abstract][Full Text] [Related]
39. Characterization of the DIM series of BALB/c preneoplasms for mouse mammary tumor virus-mediated oncogenesis. Schwartz MS; Medina D Cancer Res; 1987 Nov; 47(21):5707-14. PubMed ID: 2822232 [TBL] [Abstract][Full Text] [Related]
40. Mammary gland development requires syndecan-1 to create a beta-catenin/TCF-responsive mammary epithelial subpopulation. Liu BY; Kim YC; Leatherberry V; Cowin P; Alexander CM Oncogene; 2003 Dec; 22(58):9243-53. PubMed ID: 14681683 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]